Tlando Boosts Bone Density in American Males Over 50 with Hypogonadism: 3-Year Study
Reading Time: 2 minutesIntroduction As American males age beyond 50, the maintenance of bone health becomes increasingly critical. Osteoporosis and other bone density-related conditions can significantly impact quality of life, increasing the risk of fractures and associated morbidity. Tlando, an oral testosterone replacement therapy, has been introduced as a potential aid in managing symptoms of hypogonadism. This study investigates the effects of Tlando... Read more »
